510(k) Report

510(k) · Cleared

Cleared

Heparin Dose Response Cartridge

K102953510(k) SpecialCleared Nov 4, 201031-day reviewClass II21 CFR 864.5680

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic, Inc. · JOX Analyzer, Heparin, Automated

Cleared on Nov 4, 2010 as substantially equivalent to K042070 (Medtronic Vascular, 2004) after a 31-day review. Its family tree reaches back 2 generations to 1989.

Decided
Nov 4, 2010
Review
31 days
Class
Class II
Product code
JOX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K894317 (1989). No later device cites it as a predicate yet.

  1. Root · 2 generations backK894317 Hemotec Hepcon HMS Coagulation System & Access.Hemotec, Inc. · 1989 · Recalled
  2. 1 generation backK042070 Heparin Dose Response Cartridge, Model 304-20Medtronic Vascular · 2004
  3. This deviceK102953 Heparin Dose Response CartridgeMedtronic, Inc. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K894317Hemotec Hepcon HMS Coagulation System & Access.Hemotec, Inc.19891
−1K042070Heparin Dose Response Cartridge, Model 304-20Medtronic Vascular2004—
0 (this device)K102953Heparin Dose Response CartridgeMedtronic, Inc.2010—
FIG. 1 — Lineage of K102953, 1989–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JOX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042070Heparin Dose Response Cartridge, Model 304-20
Summary page 1
…0 Product Code: lOX Classification: Class II Predicate Device Heparin Dose Response (HDR) Cartridge (K042070) cleared on October 1,2004. Comparison to Predicate Device A comparison of the modified device and the curren…
Medtronic Vascular2004—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 15.1 years on median.
  • 1 of the 2 ancestors has a recall of any class.

How does its category compare?

All JOX devices

JOX Analyzer, Heparin, Automated: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · JOX

1in 2011

2010: 22011: 1
2007high 2 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JOX

Too few JOX 510(k)s in any year since 2007 to give a median.

Recalls per year · JOX

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JOX

65in 2025

2014: 32019: 12022: 292023: 502024: 302025: 65
2007high 65 (2025) · low 0 (2007)2025

MAUDE reports naming product code JOX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—10
20102—00
20111—00
20120—00
20130—00
20140—03
20150—00
20160—00
20170—00
20180—00
20190—01
20200—00
20210—00
20220—029
20230—050
20240—030
20250—065
20260—0—

What is it indicated for?

For determining in vitro individual responses to heparinization using whole blood on the HMS Plus instrument.

For in Vitro Diagnostic Use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K102953: Heparin Dose Response Cartridge.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K102953

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026